<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38678084</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5578</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Molecular psychiatry</Title><ISOAbbreviation>Mol Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Long COVID: plasma levels of neurofilament light chain in mild COVID-19 patients with neurocognitive symptoms.</ArticleTitle><Pagination><StartPage>3106</StartPage><EndPage>3116</EndPage><MedlinePgn>3106-3116</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41380-024-02554-0</ELocationID><Abstract><AbstractText>It is well known the potential of severe acute respiratory coronavirus type 2 (SARS-CoV-2) infection to induce post-acute sequelae, a condition called Long COVID. This syndrome includes several symptoms, but the central nervous system (CNS) main one is neurocognitive dysfunction. Recently it has been demonstrated the relevance of plasma levels of neurofilament light chain (pNfL), as a biomarker of early involvement of the CNS in COVID-19. The aim of this study was to investigate the relationship between pNfL in patients with post-acute neurocognitive symptoms and the potential of NfL as a prognostic biomarker in these cases. A group of 63 long COVID patients ranging from 18 to 59 years-old were evaluated, submitted to a neurocognitive battery assessment, and subdivided in different groups, according to results. Plasma samples were collected during the long COVID assessment and used for measurement of pNfL with the Single molecule array (SIMOA) assays. Levels of pNfL were significantly higher in long COVID patients with neurocognitive symptoms when compared to HC (p&#x2009;=&#x2009;0.0031). Long COVID patients with cognitive impairment and fatigue symptoms presented higher pNfL levels when compared to long COVID patients without these symptoms, individually and combined (p&#x2009;=&#x2009;0.0263, p&#x2009;=&#x2009;0.0480, and 0.0142, respectively). Correlation analysis showed that levels of cognitive lost and exacerbation of fatigue in the neurocognitive evaluation had a significative correlation with higher pNfL levels (p&#x2009;=&#x2009;0.0219 and 0.0255, respectively). Previous reports suggested that pNfL levels are related with higher risk of severity and predict lethality of COVID-19. Our findings demonstrate that SARS-CoV-2 infection seems to have a long-term impact on the brain, even in patients who presented mild acute disease. NfL measurements might be useful to identify CNS involvement in long COVID associated with neurocognitive symptoms and to identify who will need continuous monitoring and treatment support.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Gutman</LastName><ForeName>Elisa Gouvea</ForeName><Initials>EG</Initials><Identifier Source="ORCID">0000-0003-1060-1419</Identifier><AffiliationInfo><Affiliation>Translational Neuroscience Laboratory (LabNet), Biomedical Institute, Federal University of the State of Rio de Janeiro/UNIRIO, Rio de Janeiro, RJ, ZIP CODE 20211-040, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Medicine post-graduation program, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Salvio</LastName><ForeName>Andreza Lemos</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-9256-2582</Identifier><AffiliationInfo><Affiliation>Translational Neuroscience Laboratory (LabNet), Biomedical Institute, Federal University of the State of Rio de Janeiro/UNIRIO, Rio de Janeiro, RJ, ZIP CODE 20211-040, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fernandes</LastName><ForeName>Renan Amphilophio</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0003-2505-039X</Identifier><AffiliationInfo><Affiliation>Translational Neuroscience Laboratory (LabNet), Biomedical Institute, Federal University of the State of Rio de Janeiro/UNIRIO, Rio de Janeiro, RJ, ZIP CODE 20211-040, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>Larissa Araujo</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0003-2231-752X</Identifier><AffiliationInfo><Affiliation>Translational Neuroscience Laboratory (LabNet), Biomedical Institute, Federal University of the State of Rio de Janeiro/UNIRIO, Rio de Janeiro, RJ, ZIP CODE 20211-040, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Medicine post-graduation program, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raposo-Vedovi</LastName><ForeName>Jessica Vasques</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Translational Neuroscience Laboratory (LabNet), Biomedical Institute, Federal University of the State of Rio de Janeiro/UNIRIO, Rio de Janeiro, RJ, ZIP CODE 20211-040, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alcaraz</LastName><ForeName>Helena Fran&#xe7;a</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Translational Neuroscience Laboratory (LabNet), Biomedical Institute, Federal University of the State of Rio de Janeiro/UNIRIO, Rio de Janeiro, RJ, ZIP CODE 20211-040, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Milene Ata&#xed;de</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Translational Neuroscience Laboratory (LabNet), Biomedical Institute, Federal University of the State of Rio de Janeiro/UNIRIO, Rio de Janeiro, RJ, ZIP CODE 20211-040, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Passos</LastName><ForeName>Giselle Fazzioni</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Medeiros</LastName><ForeName>Karoline Queiroz Muniz</ForeName><Initials>KQM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammerle</LastName><ForeName>Mariana Beiral</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Division of Neurology, Gaffr&#xe9;e and Guinle University Hospital, Federal University of the State of Rio de Janeiro/UNIRIO, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pires</LastName><ForeName>Karina Lebeis</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Division of Neurology, Gaffr&#xe9;e and Guinle University Hospital, Federal University of the State of Rio de Janeiro/UNIRIO, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasconcelos</LastName><ForeName>Claudia Cristina Ferreira</ForeName><Initials>CCF</Initials><AffiliationInfo><Affiliation>Division of Neurology, Gaffr&#xe9;e and Guinle University Hospital, Federal University of the State of Rio de Janeiro/UNIRIO, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leon</LastName><ForeName>Luciane Almeida Amado</ForeName><Initials>LAA</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Desenvolvimento Tecnol&#xf3;gico em Virologia. IOC/FIOCRUZ, Rio de Janeiro, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Figueiredo</LastName><ForeName>Cl&#xe1;udia Pinto</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alves-Leon</LastName><ForeName>Soniza Vieira</ForeName><Initials>SV</Initials><Identifier Source="ORCID">0000-0002-1538-6730</Identifier><AffiliationInfo><Affiliation>Translational Neuroscience Laboratory (LabNet), Biomedical Institute, Federal University of the State of Rio de Janeiro/UNIRIO, Rio de Janeiro, RJ, ZIP CODE 20211-040, Brazil. sonizavieiraalvesleon@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil. sonizavieiraalvesleon@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>E-26/210.254/2020</GrantID><Agency>Funda&#xe7;&#xe3;o Carlos Chagas Filho de Amparo &#xe0; Pesquisa do Estado do Rio de Janeiro (Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro)</Agency><Country/></Grant><Grant><GrantID>E-26/210.657/2021</GrantID><Agency>Funda&#xe7;&#xe3;o Carlos Chagas Filho de Amparo &#xe0; Pesquisa do Estado do Rio de Janeiro (Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro)</Agency><Country/></Grant><Grant><GrantID>E-26/210.273/2018</GrantID><Agency>Funda&#xe7;&#xe3;o Carlos Chagas Filho de Amparo &#xe0; Pesquisa do Estado do Rio de Janeiro (Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro)</Agency><Country/></Grant><Grant><GrantID>E-26/201.040/2021</GrantID><Agency>Funda&#xe7;&#xe3;o Carlos Chagas Filho de Amparo &#xe0; Pesquisa do Estado do Rio de Janeiro (Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro)</Agency><Country/></Grant><Grant><GrantID>E-26/201.406/2021</GrantID><Agency>Funda&#xe7;&#xe3;o Carlos Chagas Filho de Amparo &#xe0; Pesquisa do Estado do Rio de Janeiro (Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro)</Agency><Country/></Grant><Grant><GrantID>VPPCB-005-FIO-20-2-56</GrantID><Agency>Centro de Pesquisas Aggeu Magalh&#xe3;es, Funda&#xe7;&#xe3;o Oswaldo Cruz (Centro de Pesquisas Aggeu Magalh&#xe3;es, FIOCRUZ)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Psychiatry</MedlineTA><NlmUniqueID>9607835</NlmUniqueID><ISSNLinking>1359-4184</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016900">Neurofilament Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C044882">neurofilament protein L</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016900" MajorTopicYN="Y">Neurofilament Proteins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>28</Day><Hour>7</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>23</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38678084</ArticleId><ArticleId IdType="pmc">PMC11449780</ArticleId><ArticleId IdType="doi">10.1038/s41380-024-02554-0</ArticleId><ArticleId IdType="pii">10.1038/s41380-024-02554-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol. 2021;8:1073&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, et al. Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res. 2020;20(Dec):1144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta EM, Batra A, Clark JR, Shlobin NA, Hoffman SC, Orban ZS, et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. 2020;7(Nov):2221&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7664279</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-S&#xe1;nchez CM, D&#xed;az-Maroto I, Fern&#xe1;ndez-D&#xed;az E, S&#xe1;nchez-Larsen &#xc1;, Layos-Romero A, Garc&#xed;a-Garc&#xed;a J, et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(Aug):E1060&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Koralnik IJ, Tyler KL. COVID-19: a global threat to the nervous system. Vol. 88. Annals of Neurology. John Wiley and Sons Inc.; 2020. p. 1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300753</ArticleId><ArticleId IdType="pubmed">32506549</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson BA, Visvabharathy L, Ali ST, Kang AK, Patel TR, Clark JR. et al. Plasma biomarkers of neuropathogenesis in hospitalized patients with COVID-19 and those with postacute sequelae of SARS-CoV-2 infection. Neurol(R) Neuroimmunol Neuroinflamm. 2022;9:e1151</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8901169</ArticleId><ArticleId IdType="pubmed">35256481</ArticleId></ArticleIdList></Reference><Reference><Citation>del Rio C, Collins LF, Malani P. Long-term health consequences of COVID-19. J Am Med Assoc. 2020;324:1723&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8019677</ArticleId><ArticleId IdType="pubmed">33031513</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler M, Pollak TA, Rooney AG, Michael BD, Nicholson TR. Neuropsychiatric complications of covid-19. Vol. 371, The BMJ. BMJ Publishing Group; 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33051183</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(May):416&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(Jan):220&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(Sep):e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T. Neurological infection with SARS-CoV-2&#x2014;the story so far. Vol. 17. Nature Reviews Neurology. Nature Research; 2021. p. 65&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7789883</ArticleId><ArticleId IdType="pubmed">33414554</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC. Could SARS-CoV-2 spike protein be responsible for long-COVID syndrome? Vol. 59. Molecular Neurobiology. Springer; 2022. p. 1850&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet. Facing up to long COVID. Vol. 396, The Lancet. Lancet Publishing Group; 2020. p. 1861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, et al. Neurofilaments as biomarkers in neurological disorders. Vol. 14. Nature Reviews Neurology. Nature Publishing Group; 2018. p. 577&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">30171200</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. Journal of Neurology, Neurosurgery and Psychiatry. BMJ Publishing Group; 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">30967444</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendricks R, Baker D, Brumm J, Davancaze T, Harp C, Herman A, et al. Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood. Bioanalysis. 2019;11:1405&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">31401845</ArticleId></ArticleIdList></Reference><Reference><Citation>Delcoigne B, Manouchehrinia A, Barro C, Benkert P, Michalak Z, Kappos L, et al. Blood neurofilament light levels segregate treatment effects in multiple sclerosis. Neurology. 2020;94:e1201&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7387108</ArticleId><ArticleId IdType="pubmed">32047070</ArticleId></ArticleIdList></Reference><Reference><Citation>Moscoso A, Grothe MJ, Ashton NJ, Karikari TK, Lantero Rodr&#xed;guez J, Snellman A, et al. Longitudinal associations of blood phosphorylated Tau181 and neurofilament light chain with neurodegeneration in Alzheimer disease. JAMA Neurol. 2021;78:396&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802009</ArticleId><ArticleId IdType="pubmed">33427873</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisse AL, Pitarokoili K, Leppert D, Motte J, Pedreiturria X, Kappos L, et al. Serum neurofilament light chain as outcome marker for intensive care unit patients. J Neurol. 2021;268:1323&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7990850</ArticleId><ArticleId IdType="pubmed">33098034</ArticleId></ArticleIdList></Reference><Reference><Citation>Moseby-Knappe M, Mattsson N, Nielsen N, Zetterberg H, Blennow K, Dankiewicz J, et al. Serum neurofilament light chain for prognosis of outcome after cardiac arrest. JAMA Neurol. 2019;76(Jan):64&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6440255</ArticleId><ArticleId IdType="pubmed">30383090</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper J, Stukas S, Hoiland RL, Fergusson NA, Thiara S, Foster D, et al. Quantification of neurological blood-based biomarkers in critically Ill patients with coronavirus disease 2019. Crit Care Explor. 2020;2(Oct):e0238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535554</ArticleId><ArticleId IdType="pubmed">33063038</ArticleId></ArticleIdList></Reference><Reference><Citation>Ameres M, Brandstetter S, Toncheva AA, Kabesch M, Leppert D, Kuhle J, et al. Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19. Vol. 267, Journal of Neurology. Springer Science and Business Media Deutschland GmbH; 2020. p. 3476&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7345451</ArticleId><ArticleId IdType="pubmed">32647900</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay M, Ryan L, Huentelman M, Konhilas J, Hoyer-Kimura C, G Beach T, et al. Serum neurofilament light is elevated in COVID-19 positive adults in the ICU and is associated with co-morbid cardiovascular disease, neurological complications, and acuity of illness. Cardiol Cardiovasc Med. 2021;05:551&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8547787</ArticleId><ArticleId IdType="pubmed">34708189</ArticleId></ArticleIdList></Reference><Reference><Citation>Saller T, Petzold A, Zetterberg H, Kuhle J, Chappell D, von Dossow V, et al. A case series on the value of tau and neurofilament protein levels to predict and detect delirium in cardiac surgery patients. Biomed Pap. 2019;163:241&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">31530945</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchegiani F, Recchioni R, Marcheselli F, di Rosa M, Sabbatinelli J, Matacchione G, et al. Association of admission serum levels of neurofilament light chain and in-hospital mortality in geriatric patients with COVID-19. Journal of Neurology. Springer Science and Business Media Deutschland GmbH; 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9483416</ArticleId><ArticleId IdType="pubmed">36114298</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo R, Lor&#xe9; NI, Finardi A, Mandelli A, Cirillo DM, Tresoldi C, et al. Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients. J Neurol. 2021;268:4436&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8108733</ArticleId><ArticleId IdType="pubmed">33973106</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Erben Y, Marquez CP, Jansen-West KR, Franco-Mesa C, Heckman MG, et al. Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19. Sci Transl Med 2021;13:eabi7643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8432951</ArticleId><ArticleId IdType="pubmed">34131052</ArticleId></ArticleIdList></Reference><Reference><Citation>Masvekar RR, Kosa P, Jin K, Dobbs K, Stack MA, Castagnoli R, et al. Prognostic value of serum/plasma neurofilament light chain for COVID-19-associated mortality. Ann Clin Transl Neurol. 2022;9:622&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9082006</ArticleId><ArticleId IdType="pubmed">35313387</ArticleId></ArticleIdList></Reference><Reference><Citation>Aamodt AH, H&#xf8;gest&#xf8;l EA, Popperud TH, Holter JC, Dyrhol-Riise AM, Tonby K, et al. Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19. J Neurol. 2021;268:3574&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7980743</ArticleId><ArticleId IdType="pubmed">33743046</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok KO, Huang Y, Tsoi MTF, Tang A, Wong SYS, Wei WI, et al. Epidemiology, clinical spectrum, viral kinetics and impact of COVID-19 in the Asia-Pacific region. Respirology. 2021;26:322&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8207122</ArticleId><ArticleId IdType="pubmed">33690946</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontes-Dantas FL, Fernandes GG, Gutman EG, De Lima EV, Antonio LS, Hammerle MB, et al. SARS-CoV-2 spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID syndrome in mice. Cell Rep. 2023;42:112189 https://linkinghub.elsevier.com/retrieve/pii/S2211124723002000.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9935273</ArticleId><ArticleId IdType="pubmed">36857178</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A. Symbol digit modalities test (SDMT). Manual (Revised). Los Angeles: Western Psychological Services; 1982.</Citation></Reference><Reference><Citation>Gim&#xe9;nez-Garz&#xf3; C, Garc&#xe9;s JJ, Urios A, Mangas-Losada A, Garc&#xed;a-Garc&#xed;a R, Gonz&#xe1;lez-L&#xf3;pez O, et al. The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients. PLoS ONE. 2017;12:e0171211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5287470</ArticleId><ArticleId IdType="pubmed">28146589</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheridan LK, Fitzgerald HE, Adams KM, Nigg JT, Martel MM, Puttler LI, et al. Normative symbol digit modalities test performance in a community-based sample. Arch Clin Neuropsychol. 2006;21:23&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16139470</ArticleId></ArticleIdList></Reference><Reference><Citation>Parmenter BA, Testa SM, Schretlen DJ, Weinstock-Guttman B, Benedict RHB. The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc. 2010;16:6&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">19796441</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, Villa G, de Lorenzo R, Rovere Querini P, Benedetti F. Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigue. J Psychiatr Res. 2022;155:112&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9391361</ArticleId><ArticleId IdType="pubmed">36029623</ArticleId></ArticleIdList></Reference><Reference><Citation>Grover S, Sahoo S, Mishra E, Gill KS, Mehra A, Nehra R, et al. Fatigue, perceived stigma, self-reported cognitive deficits and psychological morbidity in patients recovered from COVID-19 infection. Asian J Psychiatr. 2021;64:102815.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8379818</ArticleId><ArticleId IdType="pubmed">34455354</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarda R, Kumar A, Chandra A, Bir M, Kumar S, Soneja M, et al. Prevalence of Long COVID-19 and its Impact on Quality of Life Among Outpatients With Mild COVID-19 Disease at Tertiary Care Center in North India. J Patient Exp. 2022;9;1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9358596</ArticleId><ArticleId IdType="pubmed">35957651</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristillo V, Pilotto A, Piccinelli SC, Gipponi S, Leonardi M, Bezzi M, et al. Predictors of &#x201c;brain fog&#x201d; 1 year after COVID-19 disease. Neurol Sci. 2022;43:5795&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9361921</ArticleId><ArticleId IdType="pubmed">35930181</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan K, Miller AK, Reiter K, Bonner-Jackson A. Neurocognitive profiles in patients with persisting cognitive symptoms associated with COVID-19. Arch Clin Neuropsychol. 2022;37:729&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903427</ArticleId><ArticleId IdType="pubmed">35136912</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Rodr&#xed;guez-Jim&#xe9;nez J, Palacios-Ce&#xf1;a M, de-la-Llave-Rinc&#xf3;n AI, Fuensalida-Novo S, Florencio LL, et al. Psychometric properties of the hospital anxiety and depression scale (HADS) in previously hospitalized COVID-19 patients. Int J Environ Res Public Health. 2022;19:9273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9367824</ArticleId><ArticleId IdType="pubmed">35954630</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjelland I, Dahl AA, Haug T, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52:69&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">11832252</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanbehzadeh S, Tavahomi M, Zanjari N, Ebrahimi-Takamjani I, Amiri-Arimi S. Physical and mental health complications post-COVID-19: scoping review. Vol. 147. Journal of Psychosomatic Research. Elsevier Inc.; 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8133797</ArticleId><ArticleId IdType="pubmed">34051516</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Pan W, Li L, Li B, Ren Y, Ma X. Prevalence of depression, anxiety, and insomnia symptoms among patients with COVID-19: a meta-analysis of quality effects model. Vol. 147. Journal of Psychosomatic Research. Elsevier Inc.; 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129994</ArticleId><ArticleId IdType="pubmed">34023580</ArticleId></ArticleIdList></Reference><Reference><Citation>Olss&#xf8;n I, Mykletun A, Dahl AA. The hospital anxiety and depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005;5:46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1343544</ArticleId><ArticleId IdType="pubmed">16351733</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs MM, Evans E, Ellis C. Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of long COVID-19. J Natl Med Assoc. 2023;115:233&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9923441</ArticleId><ArticleId IdType="pubmed">36792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Sylvester SV, Rusu R, Chan B, Bellows M, O&#x2019;Keefe C, Nicholson S. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Curr Med Res Opin. 2022;38:1391&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">35726132</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28:611.e9&#x2013;611.e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma G, Volgman AS, Michos ED. Sex differences in mortality from COVID-19 pandemic. JACC Case Rep. 2020;2:1407&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7198137</ArticleId><ArticleId IdType="pubmed">32373791</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopel J, Perisetti A, Roghani A, Aziz M, Gajendran M, Goyal H. Racial and gender-based differences in COVID-19. Front Public Health. 2020;8:418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7399042</ArticleId><ArticleId IdType="pubmed">32850607</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL. Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases. BioEssays. 2012;34:1050&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4120666</ArticleId><ArticleId IdType="pubmed">23012250</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Sabadia S, Yang D, de Havenon A, Yaghi S, Lewis A, et al. Life stressors significantly impact long-term outcomes and post-acute symptoms 12-months after COVID-19 hospitalization. J Neurol Sci. 2022;443:120487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9637014</ArticleId><ArticleId IdType="pubmed">36379135</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng F, Dai C, Cai P, Wang J, Xu L, Li J, et al. A comparison study of SARS&#x2010;CoV&#x2010;2 IgG antibody between male and female COVID&#x2010;19 patients: a possible reason underlying different outcome between sex. J Med Virol. 2020;92:2050&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267228</ArticleId><ArticleId IdType="pubmed">32383183</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart S, Newson L, Briggs TA, Grammatopoulos D, Young L, Gill P. Long COVID risk&#x2014;a signal to address sex hormones and women&#x2019;s health. Lancet Reg Health. 2021;11:100242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8561426</ArticleId><ArticleId IdType="pubmed">34746909</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonson TS, Baker TL, Banzett RB, Bishop T, Dempsey JA, Feldman JL, et al. Silent hypoxaemia in COVID-19 patients. J Physiol. 2021;599:1057&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7902403</ArticleId><ArticleId IdType="pubmed">33347610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehler J, Petzold A, Wittstock M, Kolbaske S, Gloger M, Henschel J, et al. The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy&#x2014;a prospective, pilot observational study. PLoS ONE. 2019;14:e0211184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6345472</ArticleId><ArticleId IdType="pubmed">30677080</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan D, Du T, Hong W, Chen L, Que H, Lu S, et al. Neurological complications and infection mechanism of SARS-COV-2. Vol. 6. Signal Transduction and Targeted Therapy. Springer Nature; 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8609271</ArticleId><ArticleId IdType="pubmed">34815399</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanduc D. From anti-SARS-CoV-2 immune responses to COVID-19 via molecular mimicry. Antibodies. 2020;9:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7551747</ArticleId><ArticleId IdType="pubmed">32708525</ArticleId></ArticleIdList></Reference><Reference><Citation>Felipe Cuspoca A, Isaac Estrada P, Velez-van-Meerbeke A. Molecular mimicry of SARS-CoV-2 spike protein in the nervous system: a bioinformatics approach. Comput Struct Biotechnol J. 2022;20:6041&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9605789</ArticleId><ArticleId IdType="pubmed">36317085</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C, Boesl F, Goereci Y, Gerhard A, Schweitzer F, Schroeder M, et al. Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome. Brain Behav Immun. 2023;109:139&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9841734</ArticleId><ArticleId IdType="pubmed">36657623</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim HK, Al-Rubaye HT, Almulla AF, Al-Hadrawi DS, Maes M. Chronic fatigue, depression and anxiety symptoms in long COVID are strongly predicted by neuroimmune and neuro-oxidative pathways which are caused by the inflammation during acute infection. J Clin Med. 2023;12:511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9865328</ArticleId><ArticleId IdType="pubmed">36675440</ArticleId></ArticleIdList></Reference><Reference><Citation>Etemadifar M, Nouri H, Salari M, Sedaghat N. Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse. Hum Vaccin Immunother. 2022;18:2033540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9009911</ArticleId><ArticleId IdType="pubmed">35239452</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller SH, F&#xe4;rber A, Pr&#xfc;ss H, Melzer N, Golombeck KS, K&#xfc;mpfel T, et al. Genetic predisposition in anti&#x2010;LGI1 and anti&#x2010;NMDA receptor encephalitis. Ann Neurol. 2018;83:863&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29572931</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutman EG, Fernandes RA, Raposo-Vedovi JV, Salvio AL, Duarte LA, Tardim CF, et al. Molecular Mimicry between SARS-CoV-2 Proteins and Human Self-Antigens Related with Autoimmune Central Nervous System (CNS) Disorders. Microorganisms. 2023;11(Dec):2902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10745528</ArticleId><ArticleId IdType="pubmed">38138047</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekosky ST, Kochanek PM, Valadka AB, Clark RSB, Chou SHY, Au AK, et al. Blood biomarkers for detection of brain injury in COVID-19 patients. Vol. 38. Journal of Neurotrauma. Mary Ann Liebert Inc.; 2021. p. 1&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7757533</ArticleId><ArticleId IdType="pubmed">33115334</ArticleId></ArticleIdList></Reference><Reference><Citation>Terreros-Roncal J, Moreno-Jim&#xe9;nez EP, Flor-Garc&#xed;a M, Rodr&#xed;guez-Moreno CB, Trinchero MF, Cafini F, et al. Impact of neurodegenerative diseases on human adult hippocampal neurogenesis. Science. 2021;374:1106&#x2013;13. (1979)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7613437</ArticleId><ArticleId IdType="pubmed">34672693</ArticleId></ArticleIdList></Reference><Reference><Citation>Sfera A, Bullock K, Price A, Inderias L, Osorio C. Ferrosenescence: the iron age of neurodegeneration? Mech Ageing Dev. 2018;174:63&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">29180225</ArticleId></ArticleIdList></Reference><Reference><Citation>Sfera A, Rahman L, Zapata-Mart&#xed;n del Campo CM, Kozlakidis Z. Long COVID as a tauopathy: of &#x201c;Brain Fog&#x201d; and &#x201c;Fusogen Storms&#x201d;. Int J Mol Sci. 2023;24:12648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10454863</ArticleId><ArticleId IdType="pubmed">37628830</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian T, Wu J, Chen T, Li J, Yan S, Zhou Y, et al. Long-term follow-up of dynamic brain changes in patients recovered from COVID-19 without neurological manifestations. JCI Insight. 2022;7:e155827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8876627</ArticleId><ArticleId IdType="pubmed">35191397</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourque G, Burns KH, Gehring M, Gorbunova V, Seluanov A, Hammell M, et al. Ten things you should know about transposable elements. Genome Biol. 2018;19:199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240941</ArticleId><ArticleId IdType="pubmed">30454069</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PN, Hooley P, Roden D, Davari Ejtehadi H, Rylance P, Warren P, et al. Human endogenous retroviruses: transposable elements with potential? Clin Exp Immunol. 2004;138:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1809191</ArticleId><ArticleId IdType="pubmed">15373898</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xed;a GC, Paola I, Niki K, Mariacarmela S, Juli&#xe0; B, Rafael R. Human endogenous retroviruses and cancer. Cancer Biol Med. 2016;13:483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5250606</ArticleId><ArticleId IdType="pubmed">28154780</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandi N, Erb&#xec; MC, Scognamiglio S, Tramontano E. Human endogenous retrovirus (HERV) transcriptome is dynamically modulated during SARS-CoV-2 infection and allows discrimination of COVID-19 clinical stages. Microbiol Spectr. 2023;11:e0251622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9927238</ArticleId><ArticleId IdType="pubmed">36602345</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Huang J, Zhu F. Human endogenous retroviral envelope protein syncytin-1 and inflammatory abnormalities in neuropsychological diseases. Front Psychiatry. 2018;9:422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6137383</ArticleId><ArticleId IdType="pubmed">30245643</ArticleId></ArticleIdList></Reference><Reference><Citation>Uleri E, Mei A, Mameli G, Poddighe L, Serra C, Dolei A. HIV Tat acts on endogenous retroviruses of the W family and this occurs via Toll-like receptor 4. AIDS. 2014;28:2659&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">25250834</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolei A, Uleri E, Ibba G, Caocci M, Piu C, Serra C. The aliens inside human DNA: HERV-W/MSRV/syncytin-1 endogenous retroviruses and neurodegeneration. J Infect Dev Ctries. 2015;9:577&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">26142666</ArticleId></ArticleIdList></Reference><Reference><Citation>Gholami M, Safari S, Ulloa L, Motaghinejad M. Neuropathies and neurological dysfunction induced by coronaviruses. Vol. 27. Journal of NeuroVirology. Springer Science and Business Media Deutschland GmbH; 2021. p. 380&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8117458</ArticleId><ArticleId IdType="pubmed">33983506</ArticleId></ArticleIdList></Reference><Reference><Citation>Baz-Mart&#xed;nez M, da Silva-&#xc1;lvarez S, Rodr&#xed;guez E, Guerra J, el Motiam A, Vidal A, et al. Cell senescence is an antiviral defense mechanism. Sci Rep. 2016;6:37007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5111111</ArticleId><ArticleId IdType="pubmed">27849057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang MS, Aliaga AA, Shin M, Mathotaarachchi S, Benedet AL, Pascoal TA, et al. Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer&#x2019;s disease. Mol Psychiatry. 2021;26:5989&#x2013;6001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8758474</ArticleId><ArticleId IdType="pubmed">32591633</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil M, Pirpamer L, Hofer E, Voortman MM, Barro C, Leppert D, et al. Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat Commun. 2020;11:812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7010701</ArticleId><ArticleId IdType="pubmed">32041951</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F, Milone I, Bulgarelli I, Peverelli S, Colombrita C, Maranzano A, et al. Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations. J Neurol. 2022;269:5691&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9252542</ArticleId><ArticleId IdType="pubmed">35781535</ArticleId></ArticleIdList></Reference><Reference><Citation>Havdal LB, Berven LL, Selvakumar J, Stiansen-Sonerud T, Leegaard TM, Tjade T, et al. Neurological Involvement in COVID-19 among non-hospitalized adolescents and young adults. Front Neurol. 2022;13:915712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9257204</ArticleId><ArticleId IdType="pubmed">35812102</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N, Simr&#xe9;n J, Ed&#xe9;n A, Andersson LM, Nilsson S, Ashton NJ, et al. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. EBioMedicine. 2021;70:103512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8320425</ArticleId><ArticleId IdType="pubmed">34333238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N, Ashton NJ, Andersson LM, Yilmaz A, Lindh M, Nilsson S, et al. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020;95:e1754&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32546655</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Diem L, Fregolente-Gomes L, Warncke JD, Hammer H, Friedli C, Kamber N, et al. Fatigue in post-COVID-19 syndrome: clinical phenomenology, comorbidities and association with initial course of COVID-19. J Cent Nerv Syst Dis. 2022;14:117957352211027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9130865</ArticleId><ArticleId IdType="pubmed">35633835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Islam MF, Conroy K, Cotler J, Torres C, Johnson M, et al. COVID-19 symptoms over time: comparing long-haulers to ME/CFS. Fatigue. 2021;9:59&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8411893</ArticleId><ArticleId IdType="pubmed">34484973</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL, et al. Characterization and biomarker analyses of post-covid-19 complications and neurological manifestations. Cells. 2021;10:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>